Section I
2051 – 2060 of 4733
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial
(
- Contribution to journal › Article
-
Mark
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment.
(
- Contribution to journal › Article
-
Mark
Glioblastomas, astrocytomas and oligodendrogliomas linked to Lynch syndrome.
(
- Contribution to journal › Article
-
Mark
Role of exosomes and microvesicles in hypoxia-associated tumour development and cardiovascular disease.
(
- Contribution to journal › Scientific review
-
Mark
Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohort
(
- Contribution to journal › Article
-
Mark
Plasma fetuin-A concentration, genetic variation in the AHSG gene and risk of colorectal cancer
(
- Contribution to journal › Article
-
Mark
Pre-diagnostic polyphenol intake and breast cancer survival: the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.
(
- Contribution to journal › Article
-
Mark
Cell proliferation, measured as flow cytometric S-phase fraction, is a strong prognostic indicator in FIGO stage I endometrioid endometrial carcinoma: a population-based study.
(
- Contribution to journal › Article
-
Mark
Central nervous system relapse in peripheral T-cell lymphomas: A Swedish lymphoma registry study.
(
- Contribution to journal › Article
-
Mark
Therapeutic Targeting of Nuclear Gamma-Tubulin in RB1-negative Tumors.
(
- Contribution to journal › Article